UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index

The journals of gerontology. Series A, Biological sciences and medical sciences, 2018-06, Vol.73 (7), p.980-987

2018

Volltextzugriff (PDF)

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

The Lancet (British edition), 2012-08, Vol.380 (9841), p.565-571

2012

Volltextzugriff (PDF)

Evaluating the Use of Nonrandomized Real‐World Data Analyses for Regulatory Decision Making

Clinical pharmacology and therapeutics, 2019-04, Vol.105 (4), p.867-877

2019

Volltextzugriff (PDF)

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

The journals of gerontology. Series A, Biological sciences and medical sciences, 2019-07, Vol.74 (8), p.1271-1276

2019

Volltextzugriff (PDF)

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

The Lancet (British edition), 2023-04, Vol.401 (10384), p.1293-1301

2023

Volltextzugriff (PDF)

Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare Data

The journals of gerontology. Series A, Biological sciences and medical sciences, 2020-05, Vol.75 (6), p.1120-1125

2020

Volltextzugriff (PDF)

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

The New England journal of medicine, 2019-02, Vol.380 (8), p.752-762

2019

Volltextzugriff (PDF)

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

Circulation (New York, N.Y.), 2013-09, Vol.128 (11), p.1189-1197

2013

Volltextzugriff (PDF)

A combined comorbidity score predicted mortality in elderly patients better than existing scores

Journal of clinical epidemiology, 2011-07, Vol.64 (7), p.749-759

2011

Volltextzugriff (PDF)

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

Circulation (New York, N.Y.), 2019-03, Vol.139 (10), p.1289-1299

2019

Volltextzugriff (PDF)

Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study

Annals of internal medicine, 2022-07, Vol.175 (7), p.927-937

2022

Volltextzugriff (PDF)

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

European heart journal, 2018-10, Vol.39 (38), p.3499-3507

2018

Volltextzugriff (PDF)

Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial

Journal of the American College of Cardiology, 2020-10, Vol.76 (14), p.1660-1670

2020

Volltextzugriff (PDF)

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

The American heart journal, 2013-08, Vol.166 (2), p.199-207.e15

2013

Volltextzugriff (PDF)

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

Diabetes care, 2021-08, Vol.44 (8), p.1774-1782

2021

Volltextzugriff (PDF)

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

Epidemiology (Cambridge, Mass.), 2009-07, Vol.20 (4), p.512-522

2009

Volltextzugriff (PDF)

Estimation of rank correlation for clustered data

Statistics in medicine, 2017-06, Vol.36 (14), p.2163-2186

2017

Volltextzugriff (PDF)

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial

European heart journal, 2020-08, Vol.41 (31), p.2952-2961

2020

Volltextzugriff (PDF)

Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study

Annals of internal medicine, 2021-09, Vol.174 (9), p.1214-1223

2021

Volltextzugriff (PDF)

Nonrandomized Real‐World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.817-826

2020

Volltextzugriff (PDF)

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

Journal of the American College of Cardiology, 2018-05, Vol.71 (21), p.2405-2414

2018

Volltextzugriff (PDF)

Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative

Circulation (New York, N.Y.), 2021-03, Vol.143 (10), p.1002-1013

2021

Volltextzugriff (PDF)

Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.735-737

2020

Volltextzugriff (PDF)

The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

European heart journal, 2021-03, Vol.42 (9), p.896-903

2021

Volltextzugriff (PDF)

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

The New England journal of medicine, 2022-11, Vol.387 (21), p.1923-1934

2022

Volltextzugriff (PDF)

1 – 25 von 1.490

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.347)
Mit Volltextzugriff
(1.212)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.489)
Japanisch
(233)
Französisch
(2)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(976)
Life Sciences & Biomedicine
(909)
Humans
(781)
Male
(515)
Female
(513)
Aged
(440)
Biological And Medical Sciences
(344)
Middle Aged
(341)
Medical Sciences
(328)
Risk Factors
(251)
Adult
(221)
Aged, 80 And Over
(218)
Public, Environmental & Occupational Health
(154)
Cardiovascular System & Cardiology
(139)
General & Internal Medicine
(139)
Medicine, General & Internal
(135)
Cohort Studies
(124)
Epidemiology
(120)
Cardiac & Cardiovascular Systems
(118)
Follow-Up Studies
(113)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(21)

Menü

Weitere Dienste

Einstellungen

Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

Evaluating the Use of Nonrandomized Real‐World Data Analyses for Regulatory Decision Making

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare Data

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

A combined comorbidity score predicted mortality in elderly patients better than existing scores

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial

Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

Estimation of rank correlation for clustered data

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial

Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study

Nonrandomized Real‐World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative

Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials

The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Suchergebnisse filtern